Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].
Hou FQ, Yin YL, Zeng LY, Shang J, Gong GZ, Pan C, Zhang MX, Yin CB, Xie Q, Peng YZ, Chen SJ, Mao Q, Chen YP, Mao QG, Zhang DZ, Han T, Wang MR, Zhao W, Liu JJ, Han Y, Zhao LF, Luo GH, Zhang JM, Peng J, Tan DM, Li ZW, Tang H, Wang H, Zhang YX, Li J, Zhang LL, Chen L, Jia JD, Chen CW, Zhen Z, Li BS, Niu JQ, Meng QH, Yuan H, Sun YT, Li SC, Sheng JF, Cheng J, Sun L, Wang GQ. Hou FQ, et al. Among authors: wang h, wang mr, wang gq. Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):589-596. doi: 10.3760/cma.j.issn.1007-3418.2017.08.007. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 29056008 Clinical Trial. Chinese.
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.
Hou FQ, Song LW, Yuan Q, Fang LL, Ge SX, Zhang J, Sheng JF, Xie DY, Shang J, Wu SH, Sun YT, Wei SF, Wang MR, Wan MB, Jia JD, Luo GH, Tang H, Li SC, Niu JQ, Zhou WD, Sun L, Xia NS, Wang GQ. Hou FQ, et al. Among authors: wang mr, wang gq. Theranostics. 2015 Jan 1;5(3):218-26. doi: 10.7150/thno.10636. eCollection 2015. Theranostics. 2015. PMID: 25553110 Free PMC article. Clinical Trial.
[Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C].
Feng B, Shang J, Wu SH, Chen H, Han Y, Li YQ, Zhang DZ, Zhao LF, Wei SF, Mao Q, Yin CB, Han T, Wang MR, Chen SJ, Li J, Xie Q, Zhen Z, Gao ZL, Zhang YX, Gong GZ, Yang DL, Pan C, Sheng JF, Tang H, Ning Q, Shi GF, Niu JQ, Luo GH, Sun YT, You H, Wang GQ, Zhang LL, Peng J, Zhang Q, Liu JJ, Chen CW, Chen XY, Zhao W, Wang RH, Sun L, Wei L. Feng B, et al. Among authors: wang rh, wang mr, wang gq. Zhonghua Gan Zang Bing Za Zhi. 2017 Mar 20;25(3):187-194. doi: 10.3760/cma.j.issn.1007-3418.2017.03.006. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28482405 Clinical Trial. Chinese.
[Clinical effect and safety of 144-week treatment with entecavir capsules in treatment-naïve HBeAg-positive patients with chronic hepatitis B].
Cai DC, Pan C, Yu WH, Dang SS, Li J, Wu SM, Jiang N, Wang MR, Zhang ZH, Lin F, Xin SJ, Yang YF, Shen BS, Ren H. Cai DC, et al. Among authors: wang mr. Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):597-600. doi: 10.3760/cma.j.issn.1007-3418.2017.08.008. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 29056009 Chinese.
Comparison of the long-term efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naïve HBeAg-positive patients with chronic hepatitis B: A large, multicentre, randomized controlled trials.
Cai D, Pan C, Yu W, Dang S, Li J, Wu S, Jiang N, Wang M, Zhang Z, Lin F, Xin S, Yang Y, Shen B, Ren H. Cai D, et al. Medicine (Baltimore). 2019 Jan;98(1):e13983. doi: 10.1097/MD.0000000000013983. Medicine (Baltimore). 2019. PMID: 30608440 Free PMC article. Clinical Trial.
Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy.
Fan R, Zhou B, Xu M, Tan D, Niu J, Wang H, Ren H, Chen X, Wang M, Ning Q, Shi G, Sheng J, Tang H, Bai X, Liu S, Lu F, Peng J, Sun J, Xie Q, Hou J; Chronic Hepatitis B Study Consortium. Fan R, et al. Clin Gastroenterol Hepatol. 2020 Mar;18(3):719-727.e7. doi: 10.1016/j.cgh.2019.07.046. Epub 2019 Jul 27. Clin Gastroenterol Hepatol. 2020. PMID: 31362119 Free article. Clinical Trial.
Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B.
Fan R, Peng J, Xie Q, Tan D, Xu M, Niu J, Wang H, Ren H, Chen X, Wang M, Sheng J, Tang H, Bai X, Wu Y, Zhou B, Sun J, Hou J; Chronic Hepatitis B Study Consortium. Fan R, et al. J Infect Dis. 2020 Jul 23;222(4):611-618. doi: 10.1093/infdis/jiaa136. J Infect Dis. 2020. PMID: 32211776 Clinical Trial.
Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy.
Fan R, Niu J, Ma H, Xie Q, Cheng J, Rao H, Dou X, Xie J, Zhao W, Peng J, Gao Z, Gao H, Chen X, Chen J, Li Q, Tang H, Zhang Z, Ren H, Cheng M, Liang X, Zhu C, Wei L, Jia J, Sun J, Hou J; Chronic Hepatitis B Study Consortium. Fan R, et al. Aliment Pharmacol Ther. 2021 Aug;54(3):329-338. doi: 10.1111/apt.16469. Epub 2021 Jun 22. Aliment Pharmacol Ther. 2021. PMID: 34157146
339 results